BioLineRx (BLRX) Cash from Operations Growth (1y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 85.14% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 74.39% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.23% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 158.60% |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 | 62.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 62.83% |
| Sep 30, 2025 | 78.56% |
| Jun 30, 2025 | 98.44% |
| Mar 31, 2025 | 81.64% |
| Dec 31, 2024 | -272.51% |
| Sep 30, 2024 | 0.77% |
| Jun 30, 2024 | -17.01% |
| Mar 31, 2024 | -76.01% |
| Dec 31, 2023 | 187.82% |
| Sep 30, 2023 | -14.04% |
| Jun 30, 2023 | -53.95% |
| Mar 31, 2023 | -43.50% |
| Dec 31, 2022 | -3.27% |
| Sep 30, 2022 | -73.19% |
| Jun 30, 2022 | 7.89% |
| Mar 31, 2022 | 10.32% |
| Dec 31, 2021 | -1.31% |
| Sep 30, 2021 | 8.37% |
| Jun 30, 2021 | -22.70% |
| Mar 31, 2021 | 7.55% |
| Dec 31, 2020 | -0.04% |
| Sep 30, 2020 | 11.31% |
| Jun 30, 2020 | 13.65% |
| Mar 31, 2020 | -45.78% |
| Dec 31, 2019 | -5.62% |
| Sep 30, 2019 | -2.63% |
| Jun 30, 2019 | -3.40% |
| Mar 31, 2019 | 32.10% |
| Dec 31, 2018 | 18.71% |
| Sep 30, 2018 | 3.31% |
| Jun 30, 2018 | -47.95% |
| Mar 31, 2018 | -79.46% |
| Dec 31, 2017 | -54.81% |
| Sep 30, 2017 | -108.48% |
| Jun 30, 2017 | -29.15% |
| Mar 31, 2017 | 9.35% |
| Dec 31, 2016 | -28.14% |
| Sep 30, 2016 | 22.24% |
| Jun 30, 2016 | 11.29% |
| Mar 31, 2016 | -20.65% |
| Dec 31, 2015 | 33.21% |
| Sep 30, 2015 | -18.22% |
| Jun 30, 2015 | 15.32% |
| Mar 31, 2015 | -2.27% |
| Dec 31, 2014 | -28.41% |
| Sep 30, 2014 | 25.01% |
| Jun 30, 2014 | 30.22% |
| Mar 31, 2014 | 35.53% |